Optomed logo

OPTOMED - Optomed Share Price

€5.9 0.2  4.2%

Last Trade - 18/09/20

Sector
Healthcare
Size
Small Cap
Market Cap £71.3m
Enterprise Value £67.4m
Revenue £11.7m
Position in Universe 887th / 1794
Bullish
Bearish
Unlock OPTOMED Revenue
Momentum
Relative Strength (%)
1m +16.9%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -21.5%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 12.7 15.0 13.5 16.0 +17.6%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Optomed Plc revenues decreased 21% to EUR5.6M. Net loss increased 43% to EUR2.2M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Other Operating Income decrease of 82% to EUR88K (income), Finance Expense increase from EUR164K to EUR386K (expense), Employee Benefit Expenses increase of 3% to EUR3.7M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

OPTOMED Revenue Unlock OPTOMED Revenue

Net Income

OPTOMED Net Income Unlock OPTOMED Revenue

Normalised EPS

OPTOMED Normalised EPS Unlock OPTOMED Revenue

PE Ratio Range

OPTOMED PE Ratio Range Unlock OPTOMED Revenue

Dividend Yield Range

OPTOMED Dividend Yield Range Unlock OPTOMED Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
OPTOMED EPS Forecasts Unlock OPTOMED Revenue
Profile Summary

Optomed Plc is a Finland-based company engaged in the health care technology industry. The Company provides handheld fundus cameras and software solutions with integrated artificial intelligence for screening of blinding eye diseases. Its customers include international health care organizations, hospitals, and global medical technology companies and distributors.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated December 31, 2004
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange OMX Nordic Exchange - Helsinki
Shares in Issue 13,192,144
Free Float (0.0%)
Eligible for
ISAs
SIPPs
OPTOMED Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for OPTOMED
Upcoming Events for OPTOMED
Frequently Asked Questions for Optomed
What is the Optomed share price?

As of 18/09/20, shares in Optomed are trading at €5.9, giving the company a market capitalisation of £71.3m. This share price information is delayed by 15 minutes.

How has the Optomed share price performed this year?

Shares in Optomed are currently trading at €5.9 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Optomed price has moved by % over the past year.

What are the analyst and broker recommendations for Optomed?

There are no analysts currently covering Optomed.

When will Optomed next release its financial results?

Optomed is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Optomed dividend yield?

Optomed does not currently pay a dividend.

Does Optomed pay a dividend?

Optomed does not currently pay a dividend.

When does Optomed next pay dividends?

Optomed does not currently pay a dividend.

How do I buy Optomed shares?

To buy shares in Optomed you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Optomed?

Shares in Optomed are currently trading at €5.9, giving the company a market capitalisation of £71.3m.

Where are Optomed shares listed? Where are Optomed shares listed?

Here are the trading details for Optomed:

Country of listing: Finland
Exchange: HEX
Ticker Symbol: OPTOMED
What kind of share is Optomed?

Based on an overall assessment of its quality, value and momentum, Optomed is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Optomed share price forecast 2020?

Shares in Optomed are currently priced at €5.9. At that level they are trading at 13.56% discount to the analyst consensus target price of 0.00.

Analysts covering Optomed currently have a consensus Earnings Per Share (EPS) forecast of -0.245 for the next financial year.

How can I tell whether the Optomed share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Optomed. Over the past six months, the relative strength of its shares against the market has been 48.18%. At the current price of €5.9, shares in Optomed are trading at 16.63% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Optomed PE Ratio?

We were not able to find PE ratio data for Optomed.

Who are the key directors of Optomed?

Optomed's management team is headed by:

Seppo Kopsala - CEO
Laura Piila - VPR
Niina Huikuri - VPR
Sakari Knuutti - GCN
Lars Lindqvist - CFO
Markku Myllyla - VPR
Petri Salonen - CHM
Matthew Hallam - DRC
Seppo Makinen - IND
Ingo Ramesohl - DRC
Jens Umehag - DRC
Jun Wu - DRC
Who are the major shareholders of Optomed?

Here are the top five shareholders of Optomed based on the size of their shareholding:

Universal-Investment-Gesellschaft mbH Investment Advisor/Hedge Fund
Percentage owned: 7.49% (1.05m shares)
Berenberg Bank (Asset Management) Bank and Trust
Percentage owned: 7.04% (986k shares)
Berenberg European Micro Cap Mutual Fund
Percentage owned: 7.04% (986k shares)
Aura Capital Oy Venture Capital
Percentage owned: 4.94% (692k shares)
OP Asset Management Limited Investment Advisor/Hedge Fund
Percentage owned: 4.87% (681k shares)
Similar to OPTOMED
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.